Combining Active and Passive DNA Hypomethylation

Clinical trial NCT03999723 · RECRUITING

Trial details

NCT number: NCT03999723
Sponsor: Kirsten Grønbæk
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia

Start date: 2019-09-11
Primary completion: 2025-12-01
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.